Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Melanoma/Skin Cancer
•
Dermatology
What patient characteristics or clinical scenarios guide the decision in performing slow Mohs procedures?
Related Questions
Do computerized mole-mapping tools play a role in your clinical practice?
What chemoprophylaxis, if any, would you consider in a transplant patient with numerous KC/NMSCs?
How effective is the use of genomic testing methods, such as tape strip tests, for assessing suspicious pigmented lesions in clinical practice?
Have you considered intralesional cempilumab for locally advanced NMSC/KCs prior to surgery?
How would you treat a basal cell carcinoma on the temporal skin and zygomatic area s/p excision with PNI and significant flaps for closure?
What is your preferred treatment for actinic cheilitis?
How would you manage a scalp squamous cell carcinoma s/p Mohs with high risk features who underwent placental grafting to expedite the healing process?
How frequently do you recommend skin cancer screens in your patients with kidney transplants who are on immunosuppression?
Is narrow-band ultraviolet B (nbUVB) phototherapy contraindicated or recommended with caution in patients with a personal history of melanoma?
What are your favorite strategies in fixing post-surgical depressions from facial flaps?
